Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INFLECTION POINT ACQUISITION CORP. IV (MRLN)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 2
  • 1 comments

Merlin Successfully Completes Critical Design Review for C-130J Autonomy Program with USSOCOM

Market reaction Comment Full text

HIGHWOODS PROPERTIES, INC. (HIW)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 2
  • 1 comments

Highwoods Recasts $150M Unsecured Bank Term Loan

Market reaction Comment Full text

RUBRIK, INC. (RBRK)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 4
  • 1 comments

Rubrik Reports First Quarter Fiscal Year 2027 Financial Results

Market reaction Comment Full text

CLIMB GLOBAL SOLUTIONS, INC. (CLMB)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 1
  • 1 comments

Climb Global Solutions to Host Investor Day on July 7, 2026

Market reaction Comment Full text

SUPERIOR GROUP OF COMPANIES, INC. (SGC)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 8
  • 1 comments

Superior Group of Companies to Participate in the D.A. Davidson Technology & Consumer Conference

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 4
  • 1 comments

Nyxoah Annonce une Proposition dOffre dActions Ordinaires

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 4
  • 1 comments

Nyxoah Announces Proposed Offering of Ordinary Shares

Market reaction Comment Full text

IMMUNOME INC. (IMNM)

  • Business News
  • June 04, 2026, 20:02 UTC
  • 5
  • 1 comments

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:01 UTC
  • 5
  • 1 comments

Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme

Market reaction Comment Full text

NYXOAH SA (NYXH)

  • Business News
  • June 04, 2026, 20:01 UTC
  • 6
  • 1 comments

Nyxoah Enters New Chapter of Long Term Value Creation

Market reaction Comment Full text
  • Previous
  • 2441
  • 2442
  • 2443
  • 2444
  • 2445
  • Next

Search

News categories

  • Technical Exchange News(13948)
  • Event(6229)
  • SEC News(353328)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(213901)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin